Business Standard

Sunday, December 22, 2024 | 11:35 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

US vaccinations ramp up as Moderna's Covid-19 shot receives positive review

The Food and Drug Administration said its preliminary analysis confirmed the effectiveness and safety of the vaccine developed by Moderna and the National Institutes of Health

Moderna
Premium

A panel of outside experts will offer their recommendation Thursday, with a final FDA decision expected soon thereafter

AP | PTI Washington
Hundreds more US hospitals geared up to vaccinate their workers Tuesday as federal regulators issued a positive review of a second Covid-19 vaccine needed to boost the nation's largest vaccination campaign.
 
The Food and Drug Administration said its preliminary analysis confirmed the effectiveness and safety of the vaccine developed by Moderna and the National Institutes of Health, bringing it to the cusp of US authorisation.
 
A panel of outside experts will offer their recommendation Thursday, with a final FDA decision expected soon thereafter.
 
The positive news comes as hospitals ramped up vaccinations with the shot developed by Pfizer and BioNTech,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in